Gemphire Therapeutics Inc. 4
4 · Gemphire Therapeutics Inc. · Filed May 31, 2017
Insider Transaction Report
Form 4
Gullans Steven R. Ph.D.
Director
Transactions
- Award
Employee Stock Option (right to buy)
2017-05-30+60,000→ 60,000 totalExercise: $10.26Exp: 2027-05-29→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The option vests in 12 equal consecutive monthly increments, so that all of the shares will be vested on the one year anniversary of the date of grant, subject to acceleration upon the appointment of a permanent President and Chief Executive Officer.